Search…

UBS: Lowers Alibaba Health (00241.HK) target price to HK$2.8, maintains "Sell" rating.

21/09/2026

Zhitong Finance APP has learned that UBS issued a report, lowering the target price of Alibaba Health (00241.HK) from HK$3.1 to HK$2.8, maintaining a "Sell" rating; the new target price is based on 17 times FY2028 adjusted earnings per share, previously 19 times, slightly below the average of internet healthcare peers, to reflect the company's weaker earnings growth prospects.

Latest

2 m ago

Fed's hawkish stance regains market recognition! Barclays: Oil prices and AI risks still make a full stabilization of US stocks hard to claim

2 m ago

London mining stocks opened higher as oil prices retreated. Despite a slight decline in gold prices, mining stocks still posted gains, with traders assessing the inflation outlook. Mining companies are among the world's largest consumers of diesel, and rising oil prices drive up mining costs and erode profit margins. Oil prices are falling as diplomatic efforts to end the Middle East conflict intensify. Anglo American rose 2.1%, BHP gained 1.5%, Rio Tinto added 1%, and copper miner Antofagasta climbed 2.3%.

4 m ago

Pudong Construction's (600284.SH) subsidiaries won major projects totaling 1.322 billion yuan through combined bids.

7 m ago

Hong Kong Stock Movement | Lens Technology (06613.HK) Rises Over 6%; Company Achieves Deep Layout Around Emerging Strategic Track of AI Computing Power

9 m ago

JPMorgan: Maintains "Overweight" rating on Insilico Medicine (03696.HK), target price HK$71

See all latest